Investing benefits both investors and society

Responsibility is one incentive when retail investors seek investments. Pharmaceuticals and healthcare is one of the most interesting sectors.

Read more

Orion aims to grow faster than the pharmaceutical market

Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.

Read more

Financial reviews and presentations

Orion published Interim Report for January-September 2019 on Wednesday 23 October 2019.

Read more

Capital Markets Day 2019

Orion's Capital Markets Day was held on Wednesday 22 May 2019.

Read more

Joint account shares

Information and instructions for shareholders who have shares on joint account.

Read more

Oral Darolutamide presentation at ASCO on 31 May 2019

Impact of Darolutamide on Pain and Quality of Life in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer (nmCRPC) at ASCO taking place in Chicago.

Read more

AGM 2019

The 2019 Annual General Meeting was held on 26 March 2019 in Helsinki. Read more here.

Read more

Share information

Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.

Read more

Major shareholders by votes

Monthly updated list of Orion's major shareholders by votes.

Read more

Orion's R&D Pipeline

Read more

Orion Executive Management Board

The members of the Board of Directors

Orion included in FTSE4Good Index

Orion Corporation has been included in the globally recognised FTSE4Good Index.

Read more

Our approach to corporate responsibility